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Background: Copy number variation (CNV) in the range from 2 to 12 per diploid genome is an outstanding
feature of the beta-defensin gene (DEFB) cluster on human chromosome 8p23.1 numerously demonstrated by dif-
ferent methods. So far, CNV was proven for a 115 kb region between DEFB4 and 21 kb proximal of DEFB107 but the
borders for the entire CNV repeat unit are still unknown. Our study aimed to narrow down the distal border of the
DEFB cluster.
Results: We established tests for length polymorphisms based on amplification and capillary electrophoresis with
laser-induced fluorescence (CE-LIF) analysis of seven insertion/deletion (indel) containing regions spread over the
entire cluster. The tests were carried out with 25 genomic DNAs with different previously determined cluster copy
numbers. CNV was demonstrated for six indels between ~1 kb distal of DEFB108P and 10 kb proximal of DEFB107.
In contrast, the most distal indel is not affected by CNV.
Conclusion: Our analysis fixes the minimal length of proven CNV to 157 kb including DEFB108P but excluding
DEFB109P. The distal border between CNV and non-CNV part of the DEF cluster is located in the 59 kb interval
chr8:7,171,082-7,230,128.
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The beta-defensin gene cluster (DEF cluster b) on human
chromosome 8p23.1 is one of the most prominent exam-
ples for functional-relevant copy number variation (CNV)
and has been intensively investigated over the last years.
Ten genes and pseudogenes (DEFB109P, DEFB108P,
DEFB4, HSPD1P, DEFB103, SPAG11, DEFB104, DEFB106,
DEFB105 and DEFB107) are organized in a cluster of
~218 kb embedded in different types of low copy repeats
(LCR) originating from segmental duplications. Further-
more, the DEF cluster b is embedded in one of two com-
plex segmental duplications, REPD and REPP, involved in
polymorphic inversions [1-3]. Recently, in these regions
also CNV for the FAM90A gene class was shown [4]. Due
to this repetitive structure which is refractory to analysis,
the locus is one of the few regions with a remaining* Correspondence: stau@fli-leibniz.de
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unless otherwise stated.recalcitrant gap even in the most recent human genome as-
sembly GRCh37 (hg19, February 2009). In this assembly,
two clusters - DEF cluster b1 and b2 (hg19 chr8:7,170,368-
7,366,833 and chr8: 7,669,242-7,855,043, respectively) - are
arranged in opposite direction on both sides of the gap and
slightly differ in consensus sequences (Figure 1A). In the
following, for convenience, genomic positions are given
only for the distal defensin gene cluster b1. Since the as-
sembly is based on clones from different individuals, the
arrangement is arbitrarily, in fact there is variation of the
cluster copy number (CN) between 2 and 12 among
individuals which is accompanied by sequence differences
between clusters and individuals [5-11]. Hence, determin-
ation of individual DEF cluster b CNs is of basic interest,
namely due to putative or proven association or non-
association of the CN with multiple diseases [12-24]. Even
after years, CN estimation is still a technical and meth-
odological challenge [25]. From different technologies,
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Figure 1 Beta-defensin cluster on human chromosome 8p23.1. (A) In the UCSC Genome Browser (GRCh37 hg19 chr8:7,158,554-7,855,043),
two gene clusters are arranged on both sides of a clone gap and in opposite direction, illustrated by the grey arrows and named DEF cluster b1
and b2. Segmental duplications are flanking the clusters or are part of it. (B) Zoom of DEF cluster b1 with genes / pseudogenes and the distally
located 80 kb low copy repeat (LCR) previously described [9]. Dots indicate MLPA probes, PRT amplicons and microsatellites used for individual
DEF cluster b CN determination by us and others [5,26,33]. The MLPA probe for DEFB108P (grey, in parantheses) was removed from the current
kit version due to inconsistent results. Indels investigated in this study to narrow down the CNV borders are numbered from 1 to 7.
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the most accurate ones [26-30].
By MLPA, Groth et al. have proven concordance of
the CN for all genes which were represented by probes
[5]. The kit used at the time (P139, MRC Holland http://
www.mrc-holland.com) targeted 8 genes of the cluster.
For 7 genes (DEFB4, DEFB103, SPAG11, DEFB104,
DEFB106, DEFB105 and DEFB107), the probes hybridize
to regions with no other paralogs than the DEF cluster b
copies on 8p23.1 (Figure 1B). In contrast, the eighth tar-
get DEFB108P is located in a previously identified 80-kb
low copy repeat, named LCR IV [9], with additional
paralogs on chromosome 4, 11 and 8 (~12.0 and
12.2 Mb). Since there is no evidence for transcription
except for an imperfectly mapping partial coding se-
quence (AF540980), the paralogs in the DEF cluster b
are most probably pseudogenes, whereas the chromo-
some 11 paralog is the DEFB108 gene according to the
HUGO nomenclature committee (HGNC29966). The
MLPA results for DEFB108P were not reproducible and
the probe was removed from the kit when changing to
kit version P139-B1 in June 2009.
The basic idea of PRT for CN estimation is to co-
amplify with a single primer pair CNV regions together
with paralogous loci not affected by CNV [31]. Presum-
ing equal amplification efficiency for all paralogs due to
the common primers, the non CNV affected ones serve
as calibrators assuming two copies per paralog anddiploid genome (in case of a single calibrator locus) and
allow the calculation of CN for the variable paralogs.
CNV- and non-CNV paralogs can be distinguished ei-
ther by sequence differences or - in case of indels - by
length differences of the PCR products.
DEF cluster b as the region of interest is characterized
by two opposite features with regard to the existence of
paralogous regions (Figure 1). The LCR containing
DEFB109P and DEFB108P has six paralogs at non-CNV
loci on different chromosomes [9]. For sub-regions in
the size range of PRT suited PCR products (~200-
500 bp) even 12 paralogs exist with nucleotide identities
between 85 and 99%. This makes the establishment of a
reliable PRT difficult since equal amplification of all
paralogs is questionable. To circumvent the problem,
the number of co-amplified non-CNV paralogs can be
reduced to one or two by skillful primer design.
In contrast, in the interval from the proximal LCR end
to the clone gap, only few short regions with paralogs
outside the DEF cluster exist which can be used as cali-
brators in PRTs for CN determination. CN estimations
by PRTs applied by us and others [5,6,20,27] as well as
the triplex-PRT by Aldhous et al. [26] are targeting CN-
invariant pseudogenes of the heat shock 60 kDa protein
(HSPD1; NCBI accession no. NM_002156) on several
chromosomes (GENCODE pseudogene IDs: PGO-
HUM00000X with X: 239058, 246095, 235528, 237584,
246095, 235528, 239809 [32]) and the CNV paralog
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HUM00000249546; hg19 chr8: 7,276,513-7,278,068).
Furthermore, Abu Bakar et al. applied a combination of
analyses including PRT, microsatellites and a multiallelic
length polymorphism to determine individual CN with
PRT107A as the most proximal interrogated locus, lo-
cated 21 kb proximal of DEFB107 [33].
Initially, the minimal length of the CNV region was
estimated to ~240 kb by pulsed-field gel electrophor-
esis of SfiI-digested genomic DNA after hybridization
with SPAG11 and DEFB4 probes [8] but, in a strict
sense, CNV is proven for 115 kb between the most dis-
tal MLPA probe in DEFB4 and the PRT107A amplicon
(hg19 chr8: 7,272,466 - 7,387,605). While the first
assay is rather a conservative valuation, the latter is as-
sumed to underestimate the CNV length. Respectively,
it is currently not known whether the pseudogenes
DEFB108P and DEFB109P are included in the CNV re-
gion or not.
With respect to these facts, the aim of the present
study was to narrow down the borders of CNV region of
the DEF cluster b. Their more precise determination
should allow conclusions about the CNV mechanism,
the degree of variation between individual DEF cluster b
repeat units and help to elucidate the assumed impact of
the direction of the cluster copies. To this end, either
single nucleaotide variations (SNV) or insertions/dele-
tions (indels) are suitable. Allele ratios for SNVs,
however, are much harder to quantify, e.g. by pyrose-
quencing, than it can be done for indels by length differ-
ences in electrophoresis where quantification is done on
separated size-defined single strands (CE-LIF). Accuracy
and reproducibility is lower as proven by us and others
analyzing samples with verified DEF cluster copy numbers.
For example, CN estimation of 41 samples by a pyrose-
quencing based paralog ratio test (PPRT) resulted in 21
CN underestimations of up to 2 copies (Table two in [5]).
Another PPRT resulted in better results, but also revealed
3 underestimations out of 14 analyses (Table one in [34]).
Therefore, we established a set of length polymorphism
tests based on PCR of regions with small indels. Applica-
tion of these tests to genomic DNAs from individuals with
previously determined DEF cluster CNs and estimation of
the peak area ratios provide information whether the ana-
lyzed indels are affected by CNV or not.
Results
In order to confirm or exclude CNV at multiple sites
spread over DEF cluster b, namely distal and proximal of
the outermost ones with proven CNV, we identified
indels in the DEF cluster b by two approaches. We first
checked the SNP database (NCBI dbSNP Build 137; June
26, 2012) in the DEF cluster b1 (hg19 chr8:7,170,368-
7,366,833) for indels of at least 3 nucleotides and locatedoutside of homonucleotide stretches. Furthermore we
retrieved all indels with these features previously identi-
fied by 454/Roche sequencing of four DEF cluster
enriched genomes with known CN ([11] and unpub-
lished results). This resulted in 50 indels, of which 23
were located in repetitive regions complicating primer
design. Despite this we selected 23 loci (11 repetitive, 12
non-repetitive) for further analysis that cover as evenly
as possible regions of DEF cluster b not yet tractable by
MLPA or established PRTs. Consistent results were ob-
tained for seven indels (2 repetitive, 5 non-repetitive),
named indel 1 to 7 in the order from the distal to the
proximal end of DEF cluster b1 (Figure 1B, Additional
file 1: Table S2 and S3). Three-fold replication of the as-
says with 96 DNAs resulted in unambiguous accordance
of the allele ratios with the MLPA determined CNs and
standard deviations for the area ratios <0.15 (data not
shown). The CE-LIF results for the remaining loci were
not reproducible, showed fragments of unexpected
lengths and/or the calculated fragment ratios were in-
compatible with the known CN of the test samples (data
not shown).
Indels 3, 6 and 7 are located in intergenic regions,
indels 1 and 5 in intron 1 of DEFB109P and DEFB106,
respectively, and indel 2 is 273 bp upstream of the
DEFB108P start codon. Five indels are known variations
from dbSNP, indels 1 and 2 are novel ones and were
submitted to dbSNP. The amplicon lengths range be-
tween 255 and 396 bp, the length differences between
indel variants count for 3 to 5 nucleotides.
Known indels 3 to 7
Indels 3 to 7 are located in regions for which no other
paralogs exist than the DEF cluster copies themselves.
Hence, useful for the proof of CNV are only samples
with CN > 2 that harbor clusters with both indel variants
in unequal numbers. Analyses of these samples result in
two CE-LIF signals with peak area ratios unequal 1:1.
For example, a peak area ratio (short:long) of 1:2 = 0.5 is
produced by one DEF cluster copy with the short and
two copies with the long variant (or a multiple thereof ).
Consistence with previously determined MLPA CNs 3 or
6 per diploid genome would confirm a concordant CN
at the indel site. For all indels 3 to 7, between 5 (20%)
and 9 (36%) of the 25 samples per indel were inform-
ative in this way (Additional file 1: Table S4). Though
this is a modest rate it has to be noted that the assays
are neither thought nor suitable to serve as a CN estima-
tion method but rather to find the borders of the CN
variable genomic region. In total, 34 of 125 CE-LIF elec-
tropherograms (27%) showed peak area ratios unequal
1:1 and consistent with the diploid CN previously deter-
mined by MLPA (Table 1). This evidences CNV for the
positions of indels 3 to 7.
Table 1 Peak area ratios unequal 1:1 obtained by CE-LIF
assays of indels 3 to 7 using 25 genomic DNAs with











3 1.92-2.07 2:1 3,5,6 6
0.50-0.54 1:2 3,4,5,6 6
4 1:3 ---
3:1 ---
5 0.29 1:4 7 1
0.68/0.72 2:3 4,5 2
1.48 3:2 7 1
4:1 ---
6 1:5 ---
0.47-0.58 2:4 4,5,6,7 7
2.00/2.12 4:2 3 2
5:1 ---
7 0.16 1:6 7 1
0.43 2:5 6 1





0.41/0.46 2:6 or 3:5 5,7 2
0.77 3:5 5 1
1.53 5:3 7 1
2.75 6:2 7 1
7:1 ---
Total No of tests, informative for proof
of CNV
34
Between five and nine DNAs per indel showed peak area ratios unequal 1:1
(Additional file 1: Table S3), resulting in a total of 34 electropherograms
proving CNV. Indels 4 to 6 are located between DEFB4 and DEFB107 and
therefore confirm CNV already proven by MLPA. Indels 3 and 7 demonstrate
CNV outside this region (see Figure 1).
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In contrast to indels 3 to 7, indels 1 and 2 are located in
the LCR and PCR also amplifies paralogs from loci not
affected by CNV on chromosomes 4, 8, 11 and 12. This
resembles the situation of established PRTs but requires
a strict discrimination of CN variable and invariable re-
gions by the indel variants. To check this as comprehen-
sive as possible, we retrieved the sequences of all indel 1
or 2 containing BAC clones from GenBank and moni-
tored the variant status (short or long) of the indel sites.
We identified 10 and 22 clones containing indels 1 and
2, respectively, derived from five BAC libraries (RPCI-11,
RPCI-13, CTD, CHORI-17, SCb, Additional file 1: Table
S5). In addition we mapped the clone sequences against
the human genome assembly GRCh37 (hg19) by Blastand registered the chromosomal location with the high-
est score. For comparison we also checked the chromo-
somal assignments of the clones in the nucleotide
database entry, in the UCSC genome browser and in a
locus specific assembly [9]. For indel 1 we found six
clones with the short variant, doubtlessly assigned to
DEF cluster b1 or b2, and three clones with the long
variant mapping to chromosome 12. However, we also
identified one BAC (AF252830) with the long variant
which is not represented in the GRCh37 (hg19) assembly
but maps to DEF cluster b according to the Blast result
and the previous assignment [9]. From the clones
harboring indel 2, 11 were identified with the short
variant, unambiguously mapping to the DEF cluster. 9
clones have the long variant and map to the paralogous
regions on chromosomes 4, 8 (12.0 and 12.3 Mb) or 11.
In contradiction to the presumption, two clones
(AC130379.8 and AC092111.9) with the short variant
were found mapping to chromosome 8 (12.3 Mb) and
chromosome 12, respectively. These data indicate that
neither indel 1 nor indel 2 are suited to establish a quan-
titative PRT. Nevertheless, the striking overrepresenta-
tion of the short variants of both indels among DEF
cluster copies prompted us to establish CE-LIF assays
for the qualitative assessment of CN variability.
For indel 1, paralogs are located on chromosomes 4
(9.19 Mb), 8 (12.01 and 12.26 Mb) and 12 (8.36 Mb). To re-
duce the number of co-amplified paralogs we used a reverse
primer with complete match to the DEF cluster and the
chromosome 12 paralog but 3’ mismatches to the paralogs on
chromosome 4 and 8 (12.01 and 12.26 Mb) (Additional file 1:
Figure S6). The amplified region for indel 2 has paralogs on
chromosomes 4, 8 11 and 12. In an analogous manner as for
indel 1 we aimed to avoid the amplification of the paralogs on
chr8 (7.17 / 7.86 / 12.02 / 12.26 Mb) and chr12 (8.36 Mb) by
designing a forward primer matching at his 3’end only those
on chromosome 4 (9.40 Mb), 8 (11.96 / 12.20 Mb), 11
(71.54 Mb) and the DEF cluster (Additional file 1: Figure S7).
In order to check how successful the designed primers are in
reducing the number of amplified paralogs, we cloned the
PCR products of indel 1 (three samples) and indel 2 (two sam-
ples), sequenced between 24 and 43 clones per indel and
sample and assigned the sequences to chromosomal posi-
tions according to GRCh37 (hg19) (Additional file 1: Table
S8). For indel 1 we obtained exclusively clones from the
expected paralogs (DEF cluster b and chromosome 12).
None of the clones were assigned to the undesired para-
logs on chromosome 4 and 8 (12.01 and 12.26 Mb) but 6
out of 85 sequences (~7%) represented chimera derived
from the DEF cluster b and chromosome 12. Similarly, se-
quencing clones from indel 2 revealed only clones derived
from the expected paralogs of the DEF cluster and para-
logs on chromosomes 4, 8 (11.95 and 12.20 Mb) and 11.
Furthermore, we found 3 out of 80 clones (~4%) to be
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indel 1 and 2 we observed in all non-chimeric clones ex-
clusively the short variant for the DEF cluster but the long
one for the paralogs, confirming the unequal distribution
of the indel variants among BACs derived from CNV and
non-CNV loci.
Based on these results we concluded that the short/
long ratio determined from the CE-LIF electrophero-
grams for samples with different DEF cluster CNs should
be indicative for CN variability. A positive correlation of
the variant ratio with the CN would confirm CNV
whereas a rather constant ratio would indicate CN
invariance.
In agreement with this assumption, the results of the
analyses for both indels (Figure 2, Additional file 1:
Table S9) suggests that indel 2 (Spearman rank order
correlation coefficient 1.00; P = 2x10-7) but not indel 1
(0.179 / 0.66) is included in the CNV region of the DEF
cluster.
Discussion
By PCR amplification and CE-LIF analysis of seven loci
with small indels spread over DEF cluster b we could
show that:
 CNV is confirmed by indels 4 to 7 for the region
between DEFB4 and 10 kb proximal of DEFB107
which is in agreement with MLPA and PRT results;
 beyond this region CNV is proven by indels 2 and 3
in distal direction until hg19 chr8:7,230,128 thereby
including the DEFB108P pseudogene in the CNV
region of the cluster;Figure 2 Long/short ratios for indel 1 (red) and indel 2 (blue) for the DEFB109P is not comprised in the CNV region as
proven by the indel 1 analyses.
These results suggest that the distal border of CN al-
leles with more than one DEF cluster is located in the
interval of 59,047 bp between the amplicons for indel 1
and 2, i.e. in the region hg19 chr8:7,171,082-7,230,128
(DEF cluster b1) and chr8:7,796,830-7,854,329 (DEF
cluster b2).
We tried to further narrow down the exact border of
CNV in this region by analysis of three additional indels
located between hg19 chr8:7,185,414 and chr8:7,200,941
but obtained inconsistent results most likely due to the
co-amplification of more than the expected paralogs
(data not shown).
The proof of CNV for indel 7, the most proximal vari-
ation analyzed by us, is in agreement with previously
published experiments by Abu Bakar et al. using the
multiallelic length polymorphism rs5889219 for CN
determination [33]. This analysis targets a region
overlapping with our indel 7 assay. Furthermore, the
authors confirmed CNV by a PRT amplifying hg19
chr8:7,387,449-7,387,605 (named PRT107A) which is
~11 kb proximal of indel 7. We attempted to identify
indels further from this position in proximal direction, i.e.
until the clone gap at hg19 chr8:7,474,650. In the SNP
database (dbSNP build 137) we found 23 indels according
to our criteria (>2 bp length difference of the variants and
not located in homonucleotide stretch). However, we were
unable to develop suitable length polymorphism tests due
to the repetitive sequence structure around these indels.
The designed primer pairs resulted in in-silico-PCRCN classes 2 to 5.
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tide identity.
Therefore, we conservatively estimate the minimal
length of the CNV region to 157,478 bp (indel 2 –
PRT107A).
Our approach in the LCR region of DEF cluster b is
compromised by the extremely repetitive structure
resulting in the co-amplification of numerous paralogs
from all over the genome. Moreover, formation of
chimeric products must always be taken into account
when performing PCR in regions with high nucleotide
identities.
By skillful primer design we tried to restrict the number
of amplified paralogs to a minimum, ideally to one. As
shown by cloning and sequencing of selected PCR prod-
ucts, for indel 1 only one paralog on chromosome 12 was
amplified together with the DEF cluster b copies on
chromosome 8. For indel 2, we could reduce the number
of co-amplified paralogs from nine to four. Furthermore,
we found chimeric sequences in the PCR products of both
indels. These processes, however, may have contributed to
examples with high deviation of the measured peak area
ratios for samples of the same CN (Figure 2).
Moreover, the analysis of BAC sequences showed that
the two indel alleles are not exclusively linked to either
the CNV or the non-CNV LCRs. Thus, individual ge-
nomes may contain deviating indel alleles both in the
DEF cluster b copies as well as in the paralogs used as
calibrators. The presence of such “deviating copies” in
one ore more of the analyzed samples might also have
contributed to the observed high deviations.
Due to all these limitations, the test for indel 2 is not
suitable for a reliable CN estimation of DEF cluster b
but the strong correlation between the long/short vari-
ant’s ratio and CN unambiguously proves inclusion of
indel 2 in the CN variable part of the region. Since it is
located 273 bp distal of DEFB108P, CNV is also proven
for the pseudogene.
Because we demonstrated the lack of CNV for indel 1
and the DEFB109P pseudogene, the distal border that
separates the unique, CN invariable from the CN vari-
able part of the DEF cluster must be located in the inter-
val between both indels.
Conclusion
Our analysis fixes the minimal length of proven CNV to
157 kb including DEFB108P but excluding DEFB109P.
The distal border between CNV and non-CNV part of
the DEF cluster is located in the 59 kb interval
chr8:7,171,082-7,230,128. A more exact position remains
to be identified as well as the site of the proximal border
does. Due to the repetitive character of these borders it
may also be possible, that borders vary between cluster
copies and CN alleles which would further complicate afinal evaluation. In any case, our findings underscore the
mechanistic role of the LCRs bordering the DEF cluster




DNAs are originated from: (1) The CARLA study
[35,36], a prospective cohort study of the general elderly
population (21 samples); (2) Healthy blood donors [37]
(2 samples); (3) Coriell cell lines (2 samples). DNA-
preparation and DEF cluster b CN estimation by MLPA
was performed as previously described [5,23]. CNs are
listed in Additional file 1: Table S1.
PCR
~100 ng DNA were amplified in a total volume of 25 uL
using the BioMix (Bio-25012) PCR-Premix (Bioline
GmbH Luckenwalde, Germany) with 1 pmol of each pri-
mer listed in Additional file 1: Table S2, supplied by
Metabion (Martinsried, Germany). The reverse primers
were 5’-6-carboxyfluorescein (FAM)-labeled. The PCR
conditions were as follows: pre-denaturation at 95°C for
2 minutes, 30 cycles of denaturation at 95°C for 30 sec-
onds followed by annealing at 52°C for 30 seconds and
elongation at 72°C for 1:30 minutes, final elongation at
72°C for 30 minutes and cooling at 18°C for 2 minutes.
Capillary electrophoresis with laser-induced fluorescence
(CE-LIF)
The FAM-labeled PCR products were appropriately di-
luted (between 1/30 and 1/500) and 1 μl dilution was
supplemented with 10 μl HiDi-formamide (Roth, Karls-
ruhe, Germany) and 0.5 μl of GeneScan ROX 500 size
standard (Applied Biosystems, Darmstadt, Germany).
The mixture was denatured at 94°C for 3 min, and sub-
sequently cooled on ice. The denatured products were
then separated on an ABI 3730 capillary sequencer and
analyzed with the GeneMapper 4.0 software (Applied
Biosystems, Darmstadt, Germany).
Cloning and Sanger sequencing (indels 1 and 2)
PCRs were carried out as described above with un-
labeled primers using the DNAs 1105126, 3208698,
2121707 (indel 1) and 1101938, 3216315 (indel 2). The
PCR products were cloned into pCR2.1 by the TOPO
TA Cloning Kit (Invitrogen, Darmstadt, Germany) ac-
cording to the manufacturer's instructions. Colonies
were picked (indel 1: 32 for each DNA / indel 2: 48 for
each DNA) and grown in LB Broth supplemented with
ampicillin. Plasmid DNA was isolated from the cultures
by automated Qiaprep (Qiagen, Hilden, Germany) and
inserts were sequenced on a capillary sequencer ABI
3730 using the M13 reverse universal primer.
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